SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with improving money flow, Thu Apr 17th - #UPB #SHFS #AOBI #AGEN #CMRX #DXPE #IMG #JANX #KOD #TATT #PFBC #NEXN #WBX #SBH #RMT #ORN #LEO #FBMS - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Chimerix Reports Earnings as $935M Jazz Buyout and FDA Drug Review Advance Chimerix posts $23M Q4 loss while advancing dual catalysts: FDA's dordaviprone review for glioma treatment and Jazz Pharma's $8.55/share acquisition offer.

#CMRX Chimerix Reports Fourth Quarter and Year End 2024 Financial Results

www.stocktitan.net/news/CMRX/chimerix-repor...

Kuehn Law Investigates Potential Claims for BRDG, CMRX, WBA, and SYTA Investors Regarding Mergers Kuehn Law is probing potential claims related to mergers involving Bridge, Chimerix, Walgreens, and Siyata. Shareholders are urged to act quickly.

Kuehn Law Investigates Potential Claims for BRDG, CMRX, WBA, and SYTA Investors Regarding Mergers #USA #New_York #Kuehn_Law #BRDG #CMRX

Halper Sadeh LLC Investigates Companies for Potential Shareholder Violations Halper Sadeh LLC is probing several companies for potential breaches of federal securities laws affecting their shareholders, focusing on CMRX, WBA, and BLUE.

Halper Sadeh LLC Investigates Companies for Potential Shareholder Violations #United_States #New_York #Halper_Sadeh #BLUE #CMRX #WBA

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Most searched small-cap stocks, Wed Mar 5th - #RIG #QGTS #WOLF #JBLU #APLD #CLSK #VRN #RXRX #CDXC #RIOT #BTE #IQ #BTG #CMRX #WULF #SMR #RGTI #GV #GRRR #BBAI - More: - crystalequityresearch.com/SmCpStr/ - #smallcap

Halper Sadeh LLC Launches Investigation into CMRX and GLYC for Securities Violations Halper Sadeh LLC is investigating Chimerix and GlycoMimetics for potential federal securities law violations and shareholder rights breaches.

Halper Sadeh LLC Launches Investigation into CMRX and GLYC for Securities Violations #USA #New_York #Halper_Sadeh #CMRX #GLYC

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks overbought with declining relative strength, Mon Feb 24th - #SLRC #OXSQ #LUCD #EH #CMRX #ACMR #YRD #XYF #EVRI #CION #BBDC - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Revolutionary Brain Cancer Drug Gets Fast-Track to FDA Approval: Chimerix's Hope for Untreatable Glioma FDA expedites review of Chimerix's dordaviprone, potentially the first targeted therapy for rare brain cancer. Decision expected by August 2025.

#CMRX Chimerix Announces FDA Acceptance and Priority Review of New Drug Application for Dordaviprone as Treatment for Recurrent H3 K27M-Mutant Diffuse Glioma

www.stocktitan.net/news/CMRX/chimerix-annou...

Chimerix Files FDA Application for Novel Brain Cancer Drug Dordaviprone, Secures $30M Launch Funding Chimerix submits NDA for dordaviprone targeting rare pediatric brain cancer with Priority Review request. Company secures $30M credit facility to support potential Q3 2025 launch.

#CMRX Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

www.stocktitan.net/news/CMRX/chimerix-submi...

🎯 Momentum #Options Activity trade ideas! Heavy institutional #optionsvolume far above daily average with strong consensus on direction.

AM Algo #TradeIdea from 🔥 INSIDERFINANCE.COM 🔥
#STM, #CMRX, #GOOG, #CELH, #VRAR

#OptionFlow #OptionsTrading #Trading

🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #STM 6.0x
2. #GOOGL 4.5x
3. #CMRX 3.9x
4. #GOOG 2.9x
5. #CELH 2.7x

#OptionFlow #OptionsTrading #Trading

NEWS: ( NASDAQ: #CMRX ) Banzai Charging

#StockMarket #News

Just In: ( NASDAQ: #CMRX ) Chimerix Submitting NDA for Dordaviprone to FDA This Month, Seeking Accelerated Approval for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

#StockMarket #News

Chimerix to File FDA Application for Breakthrough Brain Cancer Drug with 28% Response Rate Chimerix advances dordaviprone, potentially the first FDA-approved therapy for rare H3 K27M-mutant glioma, showing promising 10.4-month response duration in trials.

#CMRX Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

#news #stocks #StockMarket

www.stocktitan.net/news/CMRX/chimerix-to-su...

Breaking News: ( NASDAQ: #CMRX ) Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting

#StockMarket #News